| 注册
首页|期刊导航|新医学|别嘌醇超敏反应研究进展

别嘌醇超敏反应研究进展

陈泽娜 古洁若

新医学2016,Vol.47Issue(3):142-145,4.
新医学2016,Vol.47Issue(3):142-145,4.DOI:10.3969/j.issn.0253-9802.2016.03.002

别嘌醇超敏反应研究进展

Research progress of allopurinol-induced hypersensitivity

陈泽娜 1古洁若1

作者信息

  • 1. 510630 广州,中山大学附属第三医院风湿免疫科
  • 折叠

摘要

Abstract

Allopurinol is one of the most common drugs for decreasing the serum uric acid,and also highly likely to cause severe adverse reactions.Based upon pharmacogenetics and immunological findings, HLA-B*58∶01 was intimately correlated with serious allopurinol-induced adverse reaction,which significantly differed among different populations.In addition,HLA-B*58∶01 gene was neither a sufficient nor necessary factor for allopurinol-related supersensitivity.Currently,HLA-B*58∶01 detection was utilized to predict the incidence of allopurinol-related supersensitivity.However,the application value remains to be further elucida-ted.In this article,pharmacogenetics and immunological studies related to allopurinol-related supersensitivity were summarized.

关键词

别嘌醇/超敏反应/HLA-B*58∶01

Key words

Allopurinol/Hypersensitivity/HLA-B*58∶01

引用本文复制引用

陈泽娜,古洁若..别嘌醇超敏反应研究进展[J].新医学,2016,47(3):142-145,4.

新医学

OACSTPCD

0253-9802

访问量0
|
下载量0
段落导航相关论文